This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mylan Launches First Ever App Of Its Generic Brand Reference® Guide

PITTSBURGH, Sept. 6, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched the first ever app of its Generic Brand Reference ® (GBR) Guide, a free reference and educational tool that helps U.S. health care professionals, patients and pharmacy students to quickly identify the generic name for a brand product and vice versa. Earlier in the year, the company made available the 2012 print edition of its GBR in a convenient, pocket-sized format. Like the print edition, the app – for iPhone ®, iPod ® touch and iPad ® * – provides an easy-to-use cross-reference guide for brand and generic product names, and in addition offers clinical support tools, including laboratory reference values, an interactive medical abbreviations converter, and functional calculators for common systems of weights and measures.

Mylan North America President Tony Mauro said: "We are pleased to offer Mylan's 2012 GBR to health care professionals in the U.S., including pharmacists, physicians and nurses, and chain and wholesale buyers. The GBR provides a comprehensive and up-to-date list of the generic and brand names for more than 2,000 separate oral and liquid dosage forms, as well as injectable and transdermal products. Mylan is committed to partnering with health care providers to optimize their time and together expand access to high quality medicine."

Mylan's printed GBR includes product portfolio sections under the Mylan Pharmaceuticals, Mylan Institutional and Mylan Specialty names and provides an easy-to-navigate, alphabetized reference source for many health care providers working in one space. The app offers all of the convenience of the printed edition on a mobile device, including content that is updated to keep the dataset current, a smart search function, easy navigation and interactive clinical support tools.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs